Drug Shortage Report for ODAN-INDOMETHACIN
| Report ID | 188073 |
| Drug Identification Number | 02231800 |
| Brand name | SANDOZ INDOMETHACIN |
| Common or Proper name | INDOMETHACIN |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | INDOMETHACIN |
| Strength(s) | 100MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 30 SUP |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-27 |
| Estimated end date | Unknown |
| Actual end date | 2023-04-04 |
| Shortage status | Resolved |
| Updated date | 2023-04-05 |
| Company comments | Sandoz divestment of the following product to Odan in Canada |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-04-05 | English | Compare |
| v5 | 2023-04-04 | French | Compare |
| v4 | 2023-04-04 | English | Compare |
| v3 | 2023-03-28 | English | Compare |
| v2 | 2023-03-27 | French | Compare |
| v1 | 2023-03-27 | English | Compare |
Showing 1 to 6 of 6